Media Insights | CardiAI™

Calgary company offers increased COVID-19 testing capability with versatile CoviLamp
CardiAl CEO Dr. Anmol Kapoor says this would allow AHS to ramp up its current capacity from the average 12,000 to 13,000 daily tests to about 100,000 tests a day

Rapid COVID-19 test -Disrupting medicine for the global good
On this episode of On the Levvel, we learn that Dr. Kapoor’s passion for equality, medicine, and education has made him a disruptor by wanting to streamline the antiquated lab process. His CoviLamp test is an advanced isothermal amplification of the COVID virus.
Calgary Biotech develops most versatile COVID test on the market







Calgary Biotech Company "CardiAI" Receives Provincial Regulatory Approval for New Laboratory
CALGARY, Alberta — Calgary-based Canadian healthcare innovator and biotech company, CardiAI Inc. announced today that its new state-of-the-art laboratory has met all the Provincial regulatory requirements to run various diagnostic tests including the COVID-19 CoviLamp-PCR and COVID-19 antibody tests.

Calgary Biotech Company "CardiAI" Receives Provincial Regulatory Approval for New Laboratory
CALGARY, Alberta — Calgary-based Canadian healthcare innovator and biotech company, CardiAI Inc. announced today that its new state-of-the-art laboratory has met all the Provincial regulatory requirements to run various diagnostic tests including the COVID-19 CoviLamp-PCR and COVID-19 antibody tests.

Calgary Biotech Company "CardiAI" Receives Provincial Regulatory Approval for New Laboratory
CALGARY, Alberta — Calgary-based Canadian healthcare innovator and biotech company, CardiAI Inc. announced today that its new state-of-the-art laboratory has met all the Provincial regulatory requirements to run various diagnostic tests including the COVID-19 CoviLamp-PCR and COVID-19 antibody tests.

Biotech Company CardiAI Opens Chest Pain Clinic in South Calgary
Calgary, Alta (June 7, 2021) - Calgary-based biotech company CardiAI is launching a new clinical trial studying the long-lasting effects of COVID-19 on the pulmonary system at its new Chest Pain Clinic (250, 8500 Blackfoot Trail SE). The ACT study (Anti-Coronavirus Therapies) will evaluate if anti-inflammatory therapies prevent the progression of COVID-19 in both inpatients and outpatients.
MP Benzen's Spring 2021 Householder Albertans’ rapid test a Covid game-changer
Vaccines and rapid testing. The reopening of our economy and an end to the societal lockdowns that have devastated entire sectors depend on easy, nation-wide access to both.
A Calgary-based biotechnology company, CardiAI, holds one of the two keys, having developed the world’s most advanced PCR diagnostic test